Division of Hematology/Oncology, Northwestern University, Chicago, IL 60611, USA.
Stem Cells Int. 2011;2011:139851. doi: 10.4061/2011/139851. Epub 2011 Oct 5.
Even though the production of orthochromatic erythroblasts can be scaled up to fulfill clinical requirements, enucleation remains one of the critical rate-limiting steps in the production of transfusable red blood cells. Mammalian erythrocytes extrude their nucleus prior to entering circulation, likely to impart flexibility and improve the ability to traverse through capillaries that are half the size of erythrocytes. Recently, there have been many advances in our understanding of the mechanisms underlying mammalian erythrocyte enucleation. This review summarizes these advances, discusses the possible future directions in the field, and evaluates the prospects for improved ex vivo production of red blood cells.
尽管可以扩大正染色红细胞的产量以满足临床需求,但去核仍然是可输用红细胞生产的关键限速步骤之一。哺乳动物红细胞在进入循环之前会排出其核,这可能赋予了它们灵活性,并提高了穿过比红细胞小一半的毛细血管的能力。最近,人们对哺乳动物红细胞去核的机制有了很多深入的了解。本综述总结了这些进展,讨论了该领域可能的未来方向,并评估了改进体外红细胞生产的前景。